Cargando…
Circulating miRNA expression over the course of colorectal cancer treatment
Colorectal cancer (CRC) is the third-most common cancer type in males and the second-most common cancer type in females, and has the second-highest overall mortality rate worldwide. Approximately 50% of patients in stage I–III develop metastases, mostly localized to the liver. All physiological cond...
Autores principales: | Kudelova, Eva, Holubekova, Veronika, Grendar, Marian, Kolkova, Zuzana, Samec, Marek, Vanova, Barbora, Mikolajcik, Peter, Smolar, Marek, Kudela, Erik, Laca, Ludovit, Lasabova, Zora |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8630815/ https://www.ncbi.nlm.nih.gov/pubmed/34868358 http://dx.doi.org/10.3892/ol.2021.13136 |
Ejemplares similares
-
Differential gene expression of immunity and inflammation genes in colorectal cancer using targeted RNA sequencing
por: Holubekova, Veronika, et al.
Publicado: (2023) -
Expression of OCT4 isoforms is reduced in primary colorectal cancer
por: Turyova, Eva, et al.
Publicado: (2023) -
Pathway Analysis of Selected Circulating miRNAs in Plasma of Breast Cancer Patients: A Preliminary Study
por: Holubekova, Veronika, et al.
Publicado: (2020) -
Hypermethylated GRIA4, a potential biomarker for an early non-invasive detection of metastasis of clinically known colorectal cancer
por: Lukacova, Eva, et al.
Publicado: (2023) -
Association of Circulating miRNA Expression with Preeclampsia, Its Onset, and Severity
por: Kolkova, Zuzana, et al.
Publicado: (2021)